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ABSTRACT  
 
Background: Original studies published over the last decade regarding time trends in dementia 
report mixed results. The aims of the present study were to use linked administrative health data 
for the province of Saskatchewan for the period 2005/06 to 2012/13 to: (1) examine 
simultaneous temporal trends in annual age- and sex-specific dementia incidence and prevalence 
among individuals aged 45 and older, and (2) stratify the changes in incidence over time by 
database of identification. 
Methods: Using a population-based retrospective cohort study design, data were extracted from 
7 provincial administrative health databases linked by a unique anonymized identification 
number. Individuals 45 years and older at first identification of dementia between April 1, 2005 
and March 31, 2013 were included, based on case definition criteria met within any one of four 
administrative health databases (hospital, physician, prescription drug, and long-term care). 
Results: Between 2005/06 and 2012/13, the 12-month age-standardized incidence rate of 
dementia declined significantly by 11.07% and the 12-month age-standardized prevalence 
increased significantly by 30.54%. The number of incident cases decreased from 3,389 to 3,270 
and the number of prevalent cases increased from 8,795 to 13,012. Incidence rate reductions 
were observed in every database of identification. 
Conclusions: We observed a simultaneous trend of decreasing incidence and increasing 
prevalence of dementia over a relatively short 8-year time period from 2005/06 to 2012/13. 
These trends indicate that the average survival time of dementia is lengthening. Continued 
observation of these time trends is warranted given the short study period. 
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INTRODUCTION  
 
 Dementia refers to a “clinical syndrome of cognitive decline” that interferes with daily 
functioning and generally occurs alongside behaviour and personality changes; the decline must 
not be the result of delirium or another condition (i.e., medical, neurological, or psychiatric) 
(Chertkow et al., 2013). The most common causes of dementia are Alzheimer’s disease (50-
75%), vascular dementia (20-30%), frontotemporal dementia (5-10%), and dementia with Lewy 
bodies (<5%) [Alzheimer’s Disease International (ADI), 2014].  
 
 The estimated global number of incident and prevalent cases of dementia in 2015 was 9.9 
million and 46.8 million respectively (ADI, 2015). Worldwide, the age- and gender-standardized 
incidence of dementia among adults aged 60-64 was an estimated 3.9 per 1,000 person years, 
doubling with every 6.3 years of age to 104.8 per 1,000 person years among adults aged 90 and 
older (ADI, 2015). High income countries generally exhibited higher incidence than low and 
middle income countries, particularly across older age groups. Furthermore, the estimated age-
standardized prevalence of dementia ranged from 1.3% among those aged 60-64 to 27.1% in 
those aged 90 and older in Central Europe (4.7% aged 60 and older), and from 2.2% among 
those aged 60-64 to 29.4% in those aged 85 and older in North Africa/Middle East (8.7% aged 
60 and older) [ADI, 2015].  
 
Original studies published over the last decade regarding time trends in dementia have 
reported mixed results in several different regions of the world. Key studies provide evidence of 
declining incidence in Rochester, United States (US) (Rocca et al., 2011) and Rotterdam, the 
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Netherlands (Schrijvers et al., 2012). Further studies indicate stable (Hall et al., 2009) or 
declining dementia prevalence in a national US sample (Langa et al., 2008), stable prevalence in 
a German sample (Doblhammer et al., 2015), and declining prevalence in Zaragoza, Spain (Lobo 
et al., 2007) and regions of England and Wales (Matthews et al., 2013). In contrast, other 
research reveals increasing dementia prevalence in northern Sweden (Mathillas et al., 2011), a 
national sample of France (Bertrand et al., 2013), Hisayama, Japan (Sekita et al., 2010), and the 
province of Alberta, Canada (Jacklin et al., 2013). Notably, the number of prevalent dementia 
cases is forecast to increase to a greater extent in low and middle (227-264%) versus high 
income countries (116%) by 2050 (ADI, 2015). 
 
To the best of our knowledge, two other original studies that examined simultaneous trends 
in dementia incidence and prevalence have been published within the last 10 years (Qiu et al., 
2013; Ng et al. 2015). In the first, a prospective cohort study of two 6-year cohorts aged 75 and 
older from 1987-89 and 2001-04 in central Stockholm, Sweden, Qiu et al., (2013) found that 
age-standardized dementia prevalence remained stable. Dementia incidence was not assessed 
directly; however, survival time based on 6-year follow-up was significantly longer for the later 
than earlier cohort, leading Qiu and colleagues to suggest that incidence decreased over the study 
period. In the second, a report based on a retrospective administrative health data study of the 
population aged 40 and older in Ontario, Canada, Ng et al. (2015) concluded that age-and sex-
adjusted dementia prevalence increased over a 7-year period between 2004/05 and 2010/11, from 
16.3 to 19.7 per 1,000 persons, and age- and sex-adjusted incidence decreased from 5.1 to 5.0 per 
1,000 persons. 
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The value of using administrative health data to examine temporal trends in dementia 
incidence and prevalence can be illustrated in three key ways. The first of these is the 
investigation of possible impacts of population-level trends in modifiable risk factors throughout 
the lifecourse (early, midlife, and late life), on the incidence and prevalence of dementia (ADI, 
2014). Currently, moderate to robust evidence exists for four domains of modifiable dementia 
risk factors: developmental (e.g., occupational status, education), psychological (e.g., depression, 
anxiety, sleep disorders), lifestyle or behaviour (e.g., cigarette use), and cardiovascular (e.g., 
obesity, cholesterol, hypertension, diabetes) (ADI, 2014). Downward trends in dementia 
incidence over time in populations with documented improvements in these risk factors (e.g., 
improved education levels and reduced hypertension) would provide further evidence of the 
association between dementia and these risk factors. The second use of administrative health data 
in secular trend studies is to provide evidence for the association between trends in dementia and 
other population-level trends and interventions, including demographics (e.g., aging; Langa et al., 
2008; Sekita et al., 2010); life expectancy (Schrijvers et al., 2012; Qiu et al., 2013); treatment of 
chronic diseases (e.g., use of statins; Langa et al., 2008; Hall et al., 2009; and hypertensive 
medications; Langa et al., 2008); treatment of cardiovascular diseases (Mathillas et al., 2011; 
Schrijvers et al., 2012); health and social care for individuals with dementia (Sekita et al., 2010; 
Mathillas et al., 2011); and standard of living (Langa et al., 2008). Third, current dementia 
projection methods are typically based on the assumption that certain factors will remain stable 
over time, such as age-specific dementia prevalence (ADI, 2015), mortality, and dementia risk 
factors (except demographics) (Rocca et al., 2011). Such projections do not adequately account 
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for ‘changing patterns in risk factors’ (Norton et al., 2013), i.e., trends in population-level factors, 
that can be accounted for in studies based on administrative health data.  
 
There have been several recent original Canadian studies concerning dementia prevalence, at 
the provincial level (Fransoo et al., 2009; Martens et al., 2010; Gill et al., 2011; Chartier et al., 
2012; Jacklin et al., 2013). However, there have been few Canadian studies of trends in dementia 
prevalence (Jacklin et al., 2013; Ng et al., 2015) and incidence (CSHA 2000; Tyas et al., 2006; 
Ng et al., 2015). Using linked administrative health data for the province of Saskatchewan for 
the time period between 2005/06 and 2012/13, the purposes of this study were to: (1) examine 
simultaneous age- and sex-specific temporal trends in dementia incidence and prevalence among 
individuals aged 45 and older, and (2) stratify any changes in incidence over time by database of 
identification. 
 
METHODS   
 
Setting  
  
 The province of Saskatchewan is the middle of three Canadian prairie provinces and covers 
651,000 km2 (Saskatchewan Bureau of Statistics, 2015). Between 2006 and 2013, the province’s 
population grew 116,021 (11.7%) from 992,302 to 1,108,303 (Statistics Canada, 2014a). The 
proportion of the population aged 45-64 grew from 25.1% to 26.1% while the proportion aged 65 
and older declined from 15% to 14.4%. The province’s population growth of 74,047 between 
2006 and 2011 (Saskatchewan Bureau of Statistics, 2014) was largely attributable to 
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interprovincial migration (12,000; 16.2%) and immigration (28,000; 37.8%), with three times 
more immigrants during this period compared to 2001-2006 (9,800) (Statistics Canada, 2012). 
Among the 13 provinces and territories, Saskatchewan’s growth during 2006-2011 was third 
largest at 6.7%, and larger than the national average at 5.9% (Statistics Canada, 2012).  
 
 Nearly all (99%) Saskatchewan residents receive provincial health care coverage (Downey et 
al., 2005) and constitute the ‘covered population’ for the present study. Federally insured 
residents (federal prison inmates, members of the Canadian Forces, and Royal Canadian 
Mounted Police) are not included in the covered population (Saskatchewan Ministry of Health, 
2012); however, their information is captured in hospital data. The Registered Indian population 
is not covered by the province’s Prescription Drug Plan (Saskatchewan Ministry of Health, 2010) 
and therefore are not included in the Prescription Drug Database employed in the current study. 
Approximately 13% of the Saskatchewan population in 2012 were classified as Registered 
Indians (Aboriginal Affairs and Northern Development Canada, 2013). 
 
Data sources 
  
 Data were extracted from 7 provincial administrative health databases linked by a unique 
anonymized personal health services number (Saskatchewan Ministry of Health, 2010). 
Databases describing the demographic characteristics and insurance coverage for the population 
of Saskatchewan included the Person Health Registration System, Saskatchewan Resident 
Geography Database, and the Vital Statistics database. The databases from which the cohort 
were identified were the Hospital Discharge Abstract Database, Physician Services Claims 
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Database, Prescription Drug Database, and the Resident Assessment Instrument – Minimum 
Data Set (RAI-MDS), i.e., Long-term Care Database.  
  
 From 2002 onwards, the Hospital Discharge Abstract Database includes 5-digit ICD-10-CA 
codes to record up to 25 diagnoses per record. The Physician Services Claims Database includes 
information used by physicians to claim payment from the provincial government for services 
provided to patients and a 3-digit ICD-9 diagnosis code associated with the service (maximum of 
one diagnosis code per service claim) (Saskatchewan Ministry of Health, 2010). The 
Prescription Drug Database includes information about drugs dispensed such as classification of 
the drug and drug identification number (DIN), with only Saskatchewan Formulary drugs 
eligible for coverage. The Long-term Care Database contains assessment information collected 
at admission to a residential care facility, at regular three-month intervals, and upon significant 
changes in clinical status (Morris et al., 2010). Admission and quarterly assessment data were 
included in the present study.  
 
Cohort  
  
 The case definition algorithm in the present study was developed over a three-stage process. 
Further details regarding the algorithm used in the current study are available elsewhere 
(Kosteniuk et al., 2015). 
 
 Individuals aged 45 years or older at their first-ever recorded identification of dementia 
between April 1, 2005 and March 31, 2013 constituted the cohort. ‘Young onset dementia’ (i.e., 
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before age of 65) is estimated to affect approximately 6-9% of all prevalent cases (WHO, 2012) 
yet the true prevalence is unknown because epidemiological studies of dementia generally 
exclude those younger than 65 years (Lambert et al., 2014). Given the distinct needs and 
experiences of individuals with young onset dementia and their families and the deficiency of 
research in this area (Ducharme et al. 2014), as well as the need for a complete epidemiological 
picture, we chose to employ an age cut-off of 45 in the present study. 
  
 A “washout” period of 5 years prior to the first identification of dementia was used to ensure 
that we correctly identified incident dementia. Individuals entered the cohort either on their index 
date or April 1, 2005, whichever was later. They remained in the cohort until the earliest 
occurrence of any of the following: death, loss of their insurance (i.e., gap in insurance coverage 
of more than 3 days), or March 31, 2013. Individuals with a gap in their insurance of more than 3 
days were not re-entered into the cohort. 
 
 Individuals were identified as a dementia case if they met at least one of the following criteria: 
>1 physician visit (ICD-9 codes 290, 294, 331, 797); >1 hospitalization (ICD-10-CA codes F00, 
F01, F02, F03, F04, F05.1, F06.8, F06.9, F09, F10.6, F10.7, F18.6, F18.7, F19.6, F19.7, G30, 
G31.0, G31.1, G91, R54); >1 prescription for a cholinesterase inhibitor (Aricept DINs 02232043, 
02232044; Exelon DINs: 02242115-02242118, 02245240; Reminyl DINs: 02244298-02244300, 
02266717, 02266725, 02266733); or – in the Long-term Care Database – a Cognitive 
Performance Scale score of 2 or over and/or a disease category of Alzheimer’s disease or 
dementia other than Alzheimer’s disease.  
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 Physician and hospital data are commonly used in administrative health data studies of 
dementia epidemiology, requiring at minimum one physician visit or hospitalization to identify a 
dementia case (Fransoo et al., 2009; Martens et al., 2010; Gill et al., 2011; Chartier et al., 2012; 
Manitoba Centre for Health Policy, 2012; Jacklin et al., 2013). Alzheimer’s disease does not 
have a diagnostic test for confirmation purposes (St Germaine-Smith et al., 2012) and 
underdiagnosis of dementia is a significant problem (Boustani et al., 2003; ADI, 2011; Connolly 
et al., 2011). Therefore, the case definition for the present study prioritized sensitivity over 
specificity by including prescription drug and long-term care data to account for dementia cases 
that may not have been identified in physician or hospital data. Other medications may be used 
to treat Alzheimer’s disease (e.g., memantine), however, the three medications included in the 
present study (Aricept, Exelon, and Reminyl) are the only cholinesterase inhibitors prescribed in 
Canada (Lee et al., 2011) and are the most commonly used treatment of Alzheimer’s disease in 
the country (Hogan, 2014). Moreover, cholinesterase inhibitors are typically not used for the 
treatment of other conditions and have been shown to have limited value in the treatment of 
attention-deficit hyperactivity disorder in a recent review (Bidwell et al. 2011).  
  
 In the Long-term Care Database, the Cognitive Performance Scale (CPS) consists of five 
measures in total: one of comatose status, two cognition (short term memory and cognitive skills 
for daily decision making), one communication, and one measure of activities of daily living 
(Morris et al., 1994). The CPS categorizes individuals into one of seven levels of cognitive 
performance based on a score of 0 to 6 (Intact = 0; 1 = Borderline intact; 2 = Mild impairment; 3 
= Moderate impairment; 4 = Moderate severe impairment; 5 = Severe impairment; 6 = Very 
severe impairment). A CPS score of 2 or higher is equivalent to an average Mini Mental State 
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Examination score of 19 or lower (Bartfay et al., 2013). This cut-off indicates dementia at the 
moderate to severe stage (Perneczky et al., 2006) and possible mild to very severe impairment 
(Morris et al., 1994).  A CPS score of 2 or higher has been validated against physician diagnosis 
and found to be 68% sensitive and 92% specific in detecting dementia (Travers et al., 2013), and 
against the Cambridge Examination for Mental Disorders of the Elderly-Revised (CAMDEX-R) 
and found to be 81% sensitive and 80% specific in detecting cognitive impairment (Paquay et al. 
2007).  
  
Independent variables 
 Age, sex, and administrative health database of first identification were the three independent 
variables included in the analysis. Age was represented by the categories of 45-54, 55-64, 65-74, 
75-84, and 85 years and older. The four administrative health datasets included hospital, 
physician, prescription drug, and long-term care.  
 
Statistical analysis 
 
 The age structure of the total cohort was used to adjust the sex-specific incidence rates and 
prevalence for age, and 95% confidence intervals (CI) were calculated for all crude and age-
standardized rates. 
 
 Incident cases were identified for each 12-month period between April 1, 2005 and March 31, 
2013. Incident cases met the case definition criteria and had not been previously identified 
during the washout period between April 1, 2000 and March 31, 2005. The numerator for each 
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12-month incidence rate was the number of people alive on April 1 of each year, who also met 
the case definition of dementia between April 1 of that year and March 31 of the following year. 
The denominator was the population at risk of developing incident dementia (i.e., after removing 
individuals with prevalent dementia for the same period, the remaining were aged 45 years or 
older on April 1 of each year with at least one day of health insurance coverage for the 12-month 
period). 
  
 Prevalent cases met the case definition criteria for each 12-month period from April 1 to 
March 31 for the years 2005 to 2013. The numerator for each 12-month prevalence was the 
number of people alive on April 1 of each year who met the case definition criteria at any time 
prior to April 1 of that year. Those individuals at risk for prevalent dementia (i.e., all individuals 
in the covered population aged 45 years or older on April 1 of each year with at least one day of 
health insurance coverage for the 12-month period) constituted the denominator. 
  
 For incidence and prevalence, we calculated the percentage changes between 2005/06 and 
2012/13 in absolute number (n), percentage, population, and age-standardized rate per 1,000, by 
dividing the difference between the two figures by the earlier figure and multiplying by 100. 
Percentage changes in age-standardized incidence rates and prevalence per 1,000 were compared 
for significant differences (p < 0.05) using the χ2 test, and 95% confidence intervals (CI) were 
calculated for all crude and age-standardized rates. All analyses were completed with SAS 9.3 
(SAS Institute Inc, Cary NC).  
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Ethical considerations 
 The University of Saskatchewan Biomedical Research Ethics Board granted ethics approval 
for this study (Bio-REB #12-339). 
 
RESULTS   
 
Incidence 
  
 As shown in Figure 1, the overall age-standardized incidence rate of dementia among 
individuals 45 years and older declined gradually and steadily from 2005/06 until 2010/11, rising 
slightly in 2011/12 before dropping again in 2012/13. Table 1 indicates that the annual 
population rose steadily each year between 2005/06 to 2012/13. As shown in Table 2, the 
population increased by 11.38% from 403,123 to 449,012 while the absolute number of overall 
incident cases dropped by 3.51% from 3,389 to 3,270 between 2005/06 and 2012/13. The overall 
age-standardized incidence rate declined significantly by 11.07% (p < 0.0001) from 8.41 to 7.48 
per 1,000 over the 8-year period. 
  
 Table 2 shows that although the female and male populations increased between 2005/06 and 
2012/13 (10.12% and 12.73% respectively), the absolute number of incident cases among 
females dropped while the absolute number of incident cases among males rose. Consequently, 
the age-standardized incidence rate decreased more markedly among females than males, 
dropping significantly by 12.97% (p < 0.0001) among females (from 8.31 to 7.23 per 1,000) 
compared to 8.39% (p = 0.0072) among males (from 8.56 to 7.84 per 1,000). The proportion of 
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incident cases attributed to females vs. males dropped as well, by 3.66% from 59.89% to 57.71%. 
The age-standardized incidence rate was slightly higher among males than females in 2005/06 
(8.56 vs. 8.31 per 1,000) and remained so in 2012/13 (7.84 vs. 7.23 per 1,000).  
  
 Overall mean age at identification in 2005/06 (81.67 + 9.98 years) did not change 
significantly (p = 0.24) in 2012/13 (81.97 + 10.70 years). As shown in Table 2, the population 
changed most substantially in the 55-64 and 65-74 age groups, increasing 16-31% among 
females and 20-32% among males. Despite this, the age-standardized incidence rate in the 55-64 
age group did not change significantly over time for either sex. Among females, significant 
declines in age-standardized incidence rates were apparent in the three oldest age groups, ranging 
from 11.97% (p = 0.0377) in those aged 85 and older [from 74.53 to 65.61 per 1,000 to 15.40% 
(p = 0.0396) in those aged 65-74 (from 4.85 to 4.10 per 1,000)]. A significant decline of 18.97% 
(p = 0.0136) in the age-standardized incidence rate among males was apparent only among those 
aged 65-74 (from 5.25 to 4.25 per 1,000). The population remained stable and neither sex in the 
45-54 age group experienced significant changes in age-standardized incidence rates over time. 
  
 In terms of the databases where incident cases of dementia were first identified, the greatest 
proportion were first identified in Long-term Care in 2005/06 (35.35%) and 2012/13 (34.98%) 
(Table 2). The declines over time in the crude incidence rates per 1,000 were significant across 
every database with the exception of Prescription Drug, with similar declines in the Physician 
(14.17%; p = 0.0007), Long-term Care (14.14%; p = 0.0002) and Hospital databases (12.97%; p 
= 0.0022). 
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Prevalence 
  
 Figure 2 shows that the overall age-standardized prevalence of dementia among those aged 45 
and older increased between 2005/06 to 2012/13. Most of the increase took place in the first four 
years of the study period, with the upward trend slowing between 2009/10 and 2012/13. Over the 
8-year period, the absolute number of overall prevalent cases rose 47.95% from 8,795 to 13,012, 
compared to an increase of 12.16% in the population from 411,918 to 462,024 (Table 1 and 
Table 3). The overall age-standardized prevalence increased significantly (p < 0.0001) by 
30.54% over time from 21.35 to 27.87 per 1,000. 
  
 As shown in Table 3, the population increased slightly more among males than females 
(13.36% vs. 11.05%), as did the absolute number of prevalent cases (51.22% vs. 46.03%). As a 
result, the age-standardized prevalence increased significantly (p < 0.0001) in both sexes, but to 
a slightly greater degree by 32.38% among males (from 20.51 to 27.15 per 1,000) compared to 
29.48% among females (from 21.88 to 28.33 per 1,000). The proportion of prevalent cases 
attributed to males relative to females rose as well, from 36.94% to 37.76% (2.33%). However, 
the age-standardized incidence rate was slightly higher among females than males in 2005/06 
(21.88 vs. 20.51 per 1,000) and remained so in 2012/13 (28.33 vs. 27.15 per 1,000).  
  
 Similar to increases in the population at risk for incident cases, the largest increases in the 
population at risk for prevalent cases took place in the 55-64 and 65-74 age groups. With the 
exception of the 45-54 age group, significant increases in age-standardized prevalence were 
apparent in every age group for both sexes. The largest increase in the age-standardized 
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prevalence for both sexes took place in the 55-64 age group (107.08% female, p < 0.0001; 
48.72% male, p < 0.0001) and the smallest increase was experienced by the 85 and older age 
group (23.98% female, p < 0.0001; 23.86% male; p < 0.0001). 
 
DISCUSSION  
 
 Using a population-based retrospective cohort design, we identified incident and prevalent 
cases of dementia between April 1, 2005 and March 31, 2013 in linked administrative health 
databases (Hospital Discharge Abstracts, Physician Service Claims, Prescription Drug, and RAI- 
MDS, i.e., Long-term Care), among individuals 45 years and older at first identification of 
dementia.  
  
 Considering the first study objective to investigate simultaneous age- and sex-specific 
temporal trends in dementia incidence and prevalence, we found the overall age-standardized 
incidence rate declined significantly by 11.07% and the age-standardized prevalence increased 
significantly by 30.54% over the 8-year study period. Overall, the incidence rate declined from 
8.41 to 7.48 per 1,000 despite an 11.38% increase in the overall population. Although both sexes 
experienced significant declines in the incidence rate over time, females experienced a slightly 
larger decrease than males (12.97% vs. 8.39%). The age-standardized incidence rate remained 
higher among males than females in 2012/13 (7.84 vs. 7.23 per 1,000) as in 2005/06 (8.56 vs. 
8.31 per 1,000). Among females, significant decreases occurred only in the three oldest age 
groups, with the largest decline in the 65-74 age group. Among males, only the 65-74 age group 
experienced a significant decline over the 8-year period. 
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 Overall, the age-standardized prevalence of dementia increased significantly by 30.54% from 
21.35 to 27.87 per 1,000, and the population increased by 12.16% between 2005/06 and 2012/13. 
Males experienced a slightly larger increase than females in the age-standardized prevalence 
over time (32.38% vs. 29.48%). The age-standardized prevalence was higher among females 
than males in 2005/06 (21.88 vs. 20.51 per 1,000) and remained so in 2012/13 (28.33 vs. 27.15 
per 1,000). Significant increases were apparent in every age group for both sexes (except those 
45-54), with the largest increment in the 55-64 age group and the smallest increment in the 85 
and older age group for both sexes.  
  
 Considering the second study objective to stratify the changes in incidence over the 8-year 
study period by database of identification, significant decreases in the crude incidence rate per 
1,000 were apparent in 3 of the 4 databases examined, with declines of 13-14% across Hospital 
Discharge Abstracts, Physician Service Claims, and RAI-MDS (i.e., Long-term Care). 
 
Incidence 
  
 Our finding of declining dementia incidence over time is consistent with four original studies 
published within the last 10 years on the topic of incidence trends. Two were separate field 
studies (i.e., two-phase studies with screening followed by a structured clinical evaluation) in 
Rotterdam, the Netherlands (Schrijvers et al., 2012) and Stockholm, Sweden (Qiu et al., 2013); 
the third study was based on medical records in Rochester, US (Rocca et al., 2011) and the most 
recent study was based on administrative health data from the province of Ontario, Canada (Ng 
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et al., 2015). Compared to a 1.4% per year decline in the current study, incidence rates declined 
an average of 2.5-3% per year in two of the four studies (Rocca et al., 2011; Schrijvers et al., 
2012), approximately 4.2% over a 7-year period in a third study (Ng et al., 2015), and an 
unspecified amount in a fourth study (Qiu et al., 2013). Similar to the present study, Schrijvers et 
al., (2012) observed a slightly greater decrease in the incidence rate over time in females than 
males; however, in contrast to the present study, the incidence rate was higher among females 
than males at both time points. 
 
Prevalence 
   
 The results of five original studies were in line with our finding of rising dementia prevalence 
over time, including separate field studies in Hisayama, Japan (Sekita et al., 2010) and northern 
Sweden (Mathillas et al., 2011) and administrative data studies in France (Bertrand et al., 2013) 
and the Canadian provinces of Alberta (Jacklin et al., 2013) and Ontario (Ng et al., 2015). At 
3.82% per year, the average annual growth in prevalence in the present study is in the lower 
range compared to other studies, which varied between 1.9-9.8% (Sekita et al., 2010; Mathillas 
et al., 2011; Bertrand et al., 2013; Jacklin et al., 2013; Ng et al., 2015). In the present study, 
males experienced a slightly larger increase than females in prevalence over time, whereas Sekita 
et al., (2010) observed the reverse. However, prevalence remained higher in females than males 
over time in the present study, in line with findings from two studies that observed increasing 
prevalence trends (Sekita et al., 2010; Mathillas et al., 2011).  
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 Contrary to the results from the present study, three original studies reported a stable temporal 
trend in dementia prevalence, including an administrative health data study in Germany 
(Doblhammer et al., 2015) and separate field studies in Indianapolis, US (Hall et al., 2009) and 
Stockholm, Sweden (Qiu et al., 2013). An additional three original studies reported a downward 
temporal trend, namely separate field studies in a national US sample (Langa et al., 2008), 
Zaragoza, Spain (Lobo et al., 2007), and regions of England and Wales (Matthews et al., 2013).  
 
Possible explanations 
  
 Recently published reviews and commentaries offer several possible explanations for 
decreasing dementia incidence and prevalence over time, as well as for increasing prevalence 
(Larson and Langa 2012; Banerjee 2013; Larson et al., 2013; Whalley and Smyth 2013; ADI, 
2015; Lee 2014; Sachev 2014; Wu et al., 2015). Preliminary supporting evidence for these 
observations is provided by findings from several original studies, wherein some of these 
explanations were tested directly (Langa et al., 2008; Hall et al., 2009; Schrijvers et al., 2012; 
Elwood et al., 2013; Mathillas et al., 2013), and others wherein speculations were made on the 
basis of population-level trends and interventions in modifiable risk factors and other factors 
(e.g., demographics) (Lobo et al., 2007; Langa et al., 2008; Sekita et al., 2010; Rocca et al., 
2011; Matthews et al., 2013; Qiu et al., 2013). First, cognitive reserve as an outcome of higher 
education and occupational complexity has been cited as a protective factor (Langa et al., 2008) 
and rising education levels and intellectual demands over time have been linked to declining 
incidence and prevalence of dementia in later cohorts (Langa et al., 2008; Hall et al., 2009; 
Rocca et al., 2011; Schrijvers et al., 2012; Matthews et al., 2013). In terms of the present study, 
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education levels have been rising in Saskatchewan, reflected in an annual 2.8% growth in the 
proportion of post-secondary graduates aged 25-64 between 2000 and 2012 (Statistics Canada, 
2013a).  
  
 Recent evidence from a 25-year longitudinal study supports an association between reduced 
risk of dementia and healthy lifestyle or behaviour (e.g., non smoking, physical activity, healthy 
diet, and limited alcohol intake) (Elwood et al., 2013). Increased uptake of healthy behaviours 
over time has been linked to declining dementia trends (Lobo et al., 2007; Hall et al., 2009; Qiu 
et al., 2013) as have reduced cardiovascular risks such as prevention of heart disease (Matthews 
et al., 2013), and decreased hypertension (Qiu et al., 2013), cholesterol (Qiu et al., 2013), and 
stroke (Rocca et al., 2011). However, a trend of increasing dementia prevalence in Japan has also 
been attributed to rising rates of obesity, hypercholesterolemia, and other metabolic disorders 
(Sekita et al., 2010). Population data indicate that while the rate of non-smoking, physical 
activity, and fruit/vegetable consumption increased in Saskatchewan over the study period, so 
too did the rates of obesity, diabetes, and high blood pressure (Elliot, 2014; Statistics Canada, 
2013b).  
  
 Recent studies support an association between temporal trends of dementia decline and 
improved treatment of vascular risks (Lobo et al., 2007; Qiu et al., 2013) such as the use of 
antithrombotic and lipid-lowering drugs (Schrijvers et al., 2012), antihypertensive medications 
(Langa et al., 2008; Hall et al., 2009) and statins (Langa et al., 2008; Hall et al., 2009; Schrijvers 
et al., 2012). The most recent available population-level data for the study period indicate 
declining annual rates of mortality in Saskatchewan due to major cardiovascular diseases 
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(Statistics Canada, 2014b), heart diseases, and cerebrovascular diseases (2003-2009) (Statistics 
Canada, 2013b).  
  
 Furthermore, increased dementia prevalence reflects lengthier duration of survival with 
dementia, possibly owing to improved care and treatment, such as better health services and 
institutional care (Sekita et al., 2010) and increased cholinesterase inhibitors prescriptions 
(Mathillas et al., 2011). Langa et al., (2008) proposed the ‘compression of cognitive morbidity’ 
hypothesis that declining dementia trends demonstrate a delay of dementia to older age, 
reflecting the positive association over time between quality of life and brain health. Mathillas et 
al., (2011) suggested that better treatment of cardiovascular risks and reduced mortality due to 
cardiovascular disease contributed to a growing pool of Swedish older adults aged 85 and older 
at risk of dementia, thereby reflecting a trend of increasing dementia prevalence in this age 
cohort.  
  
 In terms of the present study, immigration accounted for 37.8% of total population growth in 
Saskatchewan between 2006 and 2011 (Statistics Canada, 2012). It is plausible that our 
observation of declining dementia incidence despite population growth was partly due to a 
limited recognition of dementia during encounters between health care professionals and older 
adult immigrants to Saskatchewan. It is also plausible that health selective migration, whereby 
older adult immigrants have better than average health (Norman et al., 2005), was partly 
responsible for this decline.  
 
 Variations in the direction and magnitude of change over time in incidence and prevalence 
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across studies may be partly due to differences in diagnostic and classification criteria (Wu et al., 
2014) and sample or population characteristics (e.g., age cut-offs, demographic trends in 
populations). For example, given the higher prevalence among institutionalized compared to 
community-dwelling populations (Hoffman et al., 2014), excluding nursing home residents in 
field studies (e.g., Langa et al., 2008; Hall et al., 2009) possibly underestimates dementia 
prevalence overall. Methodological approaches (e.g., observation periods) may also contribute to 
variations. For instance, in comparison to field studies, administrative health data studies such as 
the present study tend to underestimate the true number of individuals with dementia because 
dementia tends to be under-recognized in the health care system (Lambert et al., 2014). 
Moreover, evidence in some high income nations of declining incidence trends (Rocca et al., 
2011; Schrijvers et al., 2012; Qiu et al., 2013;) and stable or downward prevalence trends (Lobo 
et al., 2007; Langa et al., 2008; Hall et al., 2009; Matthews et al., 2013; Qiu et al., 2013; 
Doblhammer et al., 2015), may reflect a positive association between national wealth, public 
health, and health care and therefore hinder generalization of findings to low and middle income 
countries where population aging and cardiovascular risk factors tend to be on the rise (ADI, 
2015; Wu et al., 2015). 
 
 Several interrelated factors potentially account for the limited impact of the declining 
dementia incidence rate on the prevalence of dementia in the current study. The primary 
explanation may be that the 8-year observation period was too brief to demonstrate an impact. 
Second, rising prevalence despite declining incidence in the present study indicates that survival 
time with dementia was also increasing, from 2.56 years in 2005/06 (21.53/8.41 in 2005/06) to 
3.73 years in 2012/13 (27.87/7.48). Increased survival time and prevalence may be due to 
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identification of dementia in earlier stages (ADI, 2015) and improved treatment after 
identification. Lastly, the declining provincial mortality rate and growth of the overall population 
aged 45 and older minimized the impact of declining incidence upon prevalence during the short 
8-year observation period. Beginning in 2009/10, declining incidence may have begun to 
manifest in a relatively slower increase in prevalence compared to pre-2009/10, perhaps 
signalling the beginning of a stabilizing trend in dementia prevalence.  
 
LIMITATIONS  
  
 Administrative health data is collected for purposes other than disease surveillance, and as 
such, several limitations are associated with the use of administrative health data to determine 
incidence and prevalence of dementia. First, underdiagnosis of dementia is a significant issue, 
with studies showing that 31-69% of primary care patients with dementia do not receive a formal 
documented diagnosis (Boustani et al., 2003; Bradford et al., 2009; van den Dungen et al., 2012). 
Moreover, physician services claims permit a maximum of one diagnosis code per claim, 
therefore diseases due to dementia may not be captured in these claims if patients present with 
other problems. As a result, studies based on administrative health data tend to produce 
underestimations of prevalence and incidence in comparison to field studies (Lambert et al., 
2014). However, data linkage across sectors is possible in administrative health data studies, 
allowing community and institution-dwelling populations to be examined as a whole for a more 
complete picture of dementia epidemiology, in contrast to field studies which may not combine 
these populations (e.g., Hall et al. 2009; Langa et al. 2008). Second, all of the data sources in the 
present study included the Registered Indian population, with the exception of the prescription 
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drug database. However, Registered Indians who were not identified as cases in the prescription 
drug database were likely identified in one of the other three administrative health databases. 
Therefore, their exclusion from the prescription drug database may have contributed to a minor 
underestimation of the increase in prevalence over the study period given the faster rise in 
dementia prevalence over time in First Nations compared to non-First Nations documented by 
Jacklin and colleagues (2013). Third, individuals excluded from the cohort due to interrupted 
health insurance coverage (i.e., a gap in insurance coverage of more than 3 days) accounted for 
4.2% of the total cohort over the study period. Compared to individuals without gaps, those with 
gaps were more likely to be male (40.4% with no gap versus 45.1% with gap) and Registered 
Indian (2.1% with no gap versus 9.7% with gap). Registered Indians comprised only 2.4% of the 
dementia cohort and therefore the overall estimates of incidence and prevalence reported in the 
present study were not likely affected. However, despite the small proportion of people excluded 
from the study, the sex-specific estimates of prevalence were likely to have been affected 
because of the additive effect of disproportionately excluding men. Specifically, each year the 
prevalence of dementia will be further underestimated in men compared to women because each 
year, just a few more men than women will be excluded. The difference in the prevalence of 
dementia between men and women will appear more pronounced with each passing year. Fourth, 
excluding a prescription of memantine from the case definition algorithm may have resulted in a 
slight underestimation of prevalence and incidence, in cases that had not been identified with a 
cholinesterase prescription or in one of the other three databases. Finally, our study period of 8 
years may be too short to discern a consistent and reliable pattern or trend in dementia over time. 
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CONCLUSIONS  
 
 Despite some limitations, administrative health data is a valuable research tool for tracking 
trends in dementia incidence and prevalence. The present study demonstrated that over an 8-year 
period in the province of Saskatchewan, the age-standardized incidence rate of dementia 
declined among individuals aged 45 and older while the age-standardized prevalence of dementia 
simultaneously increased. These trends indicate that the average survival time with dementia was 
also increasing, suggesting the possibilities that recognition of dementia is taking place in earlier 
stages and treatment is improving. As individuals live longer with dementia, similar to other 
chronic diseases, they require active care and monitoring for an extended period of time 
(Bergman, 2009; ADI, 2014). To spur improvements in dementia care and address increasing 
cost burdens, several G7 nations have developed national dementia strategies (France, Japan, 
United Kingdom, United States, Italy). Canada currently does not have a national dementia plan, 
despite an estimated 500,000 Canadians living with dementia in 2008 and over 100,000 incident 
cases developing each year (Dudgeon, 2010). Further reduction in dementia incidence is 
certainly possible with the type of concentrated focus that a national strategy promises, and 
future research should track these developments.  
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Figure 1  Age-standardized 12-month incidence rate of dementia among adults 45 years of age and older, 
Saskatchewan, from 2005/06 to 2012/13 
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Figure 2  Age-standardized 12-month prevalence of dementia among adults 45 years of age and older, 
Saskatchewan, from 2005/06 to 2012/13 
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Table 1   12-month incidence and prevalence of dementia among adults 45 years of age and older, Saskatchewan, from 2005/06 to 2012/13 
	 2005/06	 2006/07	 2007/08	 2008/09	 2009/10	 2010/11	 2011/12	 2012/13	
Incidence	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	
Total	population	at	risk	 403,123	 407,409	 417,605	 426,839	 431,628	 438,941	 445,187	 449,012	
	 	 	 	 	 	 	 	 	
Incident	cases	 3,389	 3,338	 3,314	 3,312	 3,320	 3,346	 3,475	 3,270	
	 	 	 	 	 	 	 	 	
Crude	incidence	 	 	 	 	 	 	 	 	
					Female	 9.77	(9.35-10.20)	 9.66	(9.24-10.08)	 9.25	(8.85-9.67)	 9.05	(8.66-9.46)	 8.80	(8.41-9.20)	 8.88	(8.49-9.27)	 8.89	(8.51-9.28)	 8.25	(7.88-8.63)	
					Male	 6.96	(6.59-7.34)	 6.64	(6.28-7.00)	 6.54	(6.19-6.90)	 6.40	(6.06-6.75)	 6.53	(6.19-6.88)	 6.31	(5.98-6.65)	 6.68	(6.34-7.03)	 6.28	(5.95-6.62)	
					Overall	 8.41	(8.13-8.69)	 8.19	(7.92-8.47)	 7.94	(7.67-8.21)	 7.76	(7.50-8.03)	 7.69	(7.43-7.96)	 7.62	(7.37-7.88)	 7.81	(7.55-8.07)	 7.04	(7.04-7.54)	
	 	 	 	 	 	 	 	 	
Age-standardized	incidence	rate	
(to	2005/06	total	Sask.	population)	
	 	 	 	 	 	 	 	
					Female	 8.31	(7.95-8.68)	 8.26	(7.91-8.63)	 8.00	(7.65-8.36)	 7.90	(7.56-8.26)	 7.72	(7.38-8.07)	 7.75	(7.42-8.10)	 7.79	(7.46-8.14)	 7.23	(6.91-7.56)	
					Male	 8.56	(8.11-9.02)	 8.20	(7.76-8.66)	 8.19	(7.75-8.64)	 8.05	(7.63-8.50)	 8.23	(7.80-8.67)	 7.95	(7.53-8.39)	 8.38	(7.96-8.82)	 7.84	(7.43-8.26)	
					Overall	 8.41	(8.13-8.69)	 8.24	(7.96-8.52)	 8.07	(7.80-8.35)	 7.96	(7.69-8.24)	 7.92	(7.65-8.19)	 7.83	(7.57-8.10)	 8.03	(7.76-8.30)	 7.48	(7.22-7.74)	
	 	 	 	 	 	 	 	 	
Prevalence	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	
Total	population	at	risk	 411,918	 417,297	 428,269	 438,069	 443,466	 451,222	 457,822	 462,024	
	 	 	 	 	 	 	 	 	
Prevalent	cases	 8,795	 9,888	 10,664	 11,230	 11,838	 12,281	 12,635	 13,012	
	 	 	 	 	 	 	 	 	
Crude	prevalence	 	 	 	 	 	 	 	 	
					Female	 26.00	(25.33-26.68)	 28.84	(28.14-29.55)	 30.47	(29.76-31.19)	 31.46	(30.74-32.19)	 32.87	(32.14-33.61)	 33.32	(32.60-34.06)	 33.79	(33.06-34.53)	 34.19	(33.46-34.93)	
					Male	 16.36	(15.81-16.93)	 18.16	(17.58-18.76)	 18.94	(18.36-19.54)	 19.42	(18.84-20.02)	 20.12	(19.53-20.72)	 20.74	(20.15-21.35)	 21.06	(20.47-21.67)	 21.82	(21.22-22.43)	
					Overall	 21.35	(20.91-21.80)	 23.70	(23.24-24.16)	 24.90	(24.44-25.37)	 25.64	(25.17-26.11)	 26.69	(26.22-27.17)	 27.22	(26.74-27.70)	 27.60	(27.13-28.08)	 28.16	(27.69-28.64)	
	 	 	 	 	 	 	 	 	
Age-standardized	prevalence	(to	
2005/06	total	Sask.	population)	
	 	 	 	 	 	 	 	
					Female	 21.88	(21.31-22.45)	 24.04	(23.45-24.63)	 25.04	(24.85-26.05)	 26.35	(25.75-26.96)	 27.37	(26.77-27.99)	 27.59	(26.99-28.20)	 28.04	(27.44-28.65)	 28.33	(27.73-28.94)	
					Male	 20.51	(19.81-21.22)	 22.65	(21.92-23.39)	 23.81	(23.07-24.86)	 24.53	(23.80-25.29)	 25.35	(24.60-26.10)	 26.06	(25.31-26.82)	 26.31	(25.57-27.07)	 27.15	(26.40-27.91)	
					Overall	 21.35	(20.91-21.80)	 23.50	(23.05-23.97)	 24.82	(24.35-25.29)	 25.65	(25.19-26.13)	 26.60	(26.13-27.07)	 27.00	(26.53-27.48)	 27.37	(26.90-27.85)	 27.87	(27.40-28.35)	
	 	 	 	 	 	 	 	 	
This document is the Author's Accepted Manuscript as submitted to the Journal.
 The definitive version of this manuscript is published in the journal International Psychogeriatrics   http://dx.doi.org/10.1017/S1041610216000818
  41 
a Test of difference between age-standardized dementia incidence rate in 2005/06 vs 2012/13 
b Change in crude rate per 1,000  
 
 
 
 
Table 2  Change in 12-month incidence of dementia among adults 45 years of age and older, Saskatchewan, 2005/06 to 2012/13 
	
2005/06	
n	=	3,389	
2012/13	
n	=	3,270	 Change	from	2005/06	to	2012/13	(%)	
	
	
	
n	
	
	
	
%	
	
	
	
Population	
	
	
Crude	rate	per	
1,000	
	
	
Age-standardized	
rate	per	1,000	
	
	
	
n	
	
	
	
%	
	
	
	
Population	
	
	
Crude	rate	per	
1,000	
	
	
Age-standardized	
rate	per	1,000	
	
	
	
n	
	
	
	
%	
	
	
	
Population	
Age-
stand.	
rate	per	
1,000	
	
	
	
p-valuea	
Female	 2,030	 59.89	 207,766	 9.77	(9.35-10.20)	 8.31	(7.95-8.68)	 1,887	 57.71	 228,782	 8.25	(7.88-8.63)	 7.23	(6.91-7.56)	 -7.04	 -3.64	 10.12	 -12.97	 <0.0001	
Male	 1,359	 40.10	 195,357	 6.96	(6.59-7.34)	 8.56	(8.11-9.02)	 1,383	 42.29	 220,230	 6.28	(5.95-6.62)	 7.84	(7.43-8.26)	 1.77	 5.46	 12.73	 -8.39	 0.0072	
Database	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		Physician	 1,023	 30.19	 403,123	 2.54	 n/a	 979	 29.94	 449,012	 2.18	 n/a	 -4.30	 -0.83	 11.38	 -14.17b	 0.0007	
		Hospital	 964	 28.44	 403,123	 2.39	 n/a	 933	 28.53	 449,012	 2.08	 n/a	 -3.22	 0.32	 11.38	 -12.97b	 0.0022	
		Prescription	
		Drug	 204	 6.02	 403,123	 0.51	 n/a	 214	 6.54	 449,012	 0.48	 n/a	 4.90	 8.64	 11.38	 -5.88
b	 0.5376	
		LTC	 1,198	 35.35	 403,123	 2.97	 n/a	 1,144	 34.98	 449,012	 2.55	 n/a	 -4.51	 -1.05	 11.38	 -14.14b	 0.0002	
Female	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		45-54	 35	 1.72	 75,340	 0.46	(0.32-0.65)	 0.47	(0.32-0.65)	 37	 1.96	 75,597	 0.49	(0.34-0.67)		 0.46	(0.32-0.63)	 5.71	 			13.95	 0.34	 -1.46	 0.8249	
		55-64	 60	 2.96	 51,927	 1.16	(0.88-1.49)	 1.15	(0.88-1.48)	 85	 4.50	 67,958	 1.25	(1.00-1.55)	 1.23	(0.99-1.53)	 	41.67	 52.03	 30.87	 7.16	 0.6390	
		65-74	 178	 8.77	 36,476	 4.88	(4.19-5.65)	 4.85	(4.17-5.62)	 165	 8.74	 42,193	 3.91	(3.34-4.55)	 4.10	(3.50-4.78)	 -7.30	 -0.34	 15.67	 -15.40	 0.0396	
		75-84	 656	 32.32	 29,487	 22.25	(20.59-24.00)	 21.91	(20.28-23.63)	 539	 28.56	 27,767	 19.41	(17.82-21.10)	 19.03	(17.47-20.69)	 -17.84	 -11.63	 -5.83	 -13.15	 0.0177	
		85+	 1,101	 54.24	 14,536	 75.74	(71.49-80.16)	 74.53	(70.35-78.88)	 1,061	 56.22	 15,267	 69.50	(65.51-73.65)	 65.61	(61.85-69.53)	 -3.63	 3.65	 5.03	 -11.97	 0.0377	
		All	ages	 2,030	 100.00	 207,766	 9.77	(9.35-10.20)	 8.31	(7.95-8.68)	 1,887	 100.00	 228,782	 8.25	(7.88-8.63)	 7.23	(6.91-7.56)	 -7.04	 0	 10.12	 -12.97	 <0.0001	
Male	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		45-54	 42	 3.09	 77,416	 0.54	(0.39-0.73)		 0.54	(0.39-0.73)	 33	 2.39	 77,592	 0.43	(0.29-0.60)	 0.40	(0.27-0.56)	 -21.43	 -22.65	 0.23	 -26.24	 0.294	
		55-64	 74	 5.45	 52,879	 1.40	(1.10-1.76)	 1.40	(1.10-1.76)	 92	 6.65	 69,958	 1.32	(1.06-1.61)	 1.30	(1.59-1.05)	 24.32	 22.02	 32.30	 -7.51	 0.6903	
		65-74	 178	 13.10	 34,121	 5.22	(4.48-6.04)	 5.25	(4.51-6.08)	 164	 11.86	 41,005	 4.00	(3.41-4.66)	 4.25	(3.63-4.96)	 -7.87	 -9.47	 20.18	 -18.97	 0.0136	
		75-84	 499	 36.72	 23,228	 21.48	(19.66-23.43)	 21.91	(20.05-23.89)	 475	 34.35	 22,849	 20.79	(18.98-22.72)	 20.86	(1905-22.80)	 -4.81	 -6.45	 -1.63	 -4.77	 0.6046	
		85+	 566	 41.65	 7,713	 73.38	(67.66-79.43)	 75.70	(69.79-81.93)	 619	 44.76	 8,826	 70.13	(64.89-75.66)	 71.46	(66.12-77.09)	 9.36	 7.47	 14.43	 -5.60	 0.4201	
		All	ages	 1,359	 100	 195,357	 6.96	(6.59-7.34)	 8.56	(8.11-9.02)	 1,383	 100.00	 220,230	 6.28	(5.95-6.62)	 7.84	(7.43-8.26)	 1.77	 0	 12.73	 -8.39	 0.0072	
Overall	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		45-54	 77	 2.27	 152,756	 0.50	(0.40-0.63)	 0.50	(0.40-0.63)	 70	 2.14	 153,189	 0.46	(0.36-0.58)	 0.43	(0.33-0.54)	 -9.09	 -5.73	 0.28	 -14.96	 0.5521	
		55-64	 134	 3.95	 104,806	 1.28	(1.07-1.51)	 1.28	(1.07-1.51)	 177	 5.41	 137,916	 1.28	(1.10-1.49)	 1.27	(1.09-1.47)	 32.09	 36.96	 31.59	 -0.91	 0.9737	
		65-74	 356	 10.50	 70,597	 5.04	(4.53-5.59)	 5.04	(4.53-5.59)	 329	 10.06	 83,198	 3.95	(3.54-4.40)	 4.18	(3.74-4.65)	 -7.58	 -4.19	 17.85	 -17.16	 0.0014	
		75-84	 1,155	 34.08	 52,715	 21.91	(20.68-23.20)	 21.91	(20.68-23.20)	 1,014	 31.01	 50,616	 20.03	(18.83-21.29)	 19.85	(18.66-21.09)	 -12.21	 -9.01	 -3.98	 -9.42	 0.0354	
		85+	 1,667	 49.19	 22,249	 74.92	(71.50-78.46)	 74.92	(71.50-78.46)	 1,680	 51.38	 24,093	 69.73	(66.55-73.02)	 67.65	(64.56-70.84)	 0.78	 4.45	 8.29	 -9.70	 0.0309	
		All	ages	 3,389	 100	 403,123	 8.41	(8.13-8.69)	 8.41	(8.13-8.69)	 3,270	 100	 449,012	 7.28	(7.04-7.54)	 7.48	(7.22-7.74)	 -3.51	 0	 11.38	 -11.07	 <0.0001	
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a Test of difference between age-standardized dementia prevalence in 2005/06 vs 2012/13  
 
 
 
 
 
 
 
 
 
Table 3  Change in 12-month prevalence of dementia among adults 45 years of age and older, Saskatchewan, 2005/06 to 2012/13 
	
2005/06	
n	=	8,795	
2012/13	
n	=	13,012	 Change	from	2005/06	to	2012/13	(%)	
	
	
n	
	
	
%	
	
	
Population	
	
Crude	prevalence	
per	1,000	
Age-standardized	
prevalence	per	1,000	
	
	
n	
	
	
%	
	
	
Population	
	
Crude	prevalence	
per	1,000	
	
Age-standardized	
prevalence	per	1,000	
	
	
n	
	
	
%	
	
	
Population	
Age-stand.	
prevalence	
per	1,000	
	
	
p-valuea	
Female	 5,546	 63.06	 213,312	 26.00	(25.33-26.68)	 21.88	(21.21-22.45)	 8,099	 62.24	 236,881	 34.19	(33.46-34.93)	 28.33	(27.73-28.94)	 46.03	 -1.36	 11.05	 29.48	 <0.0001	
Male	 3,249	 36.94	 198,606	 16.36	(15.81-16.93)	 20.51	(19.81-21.22)	 4,913	 37.76	 225,143	 21.82	(21.22-22.43)	 27.15	(26.40-27.91)	 51.22	 2.33	 13.36	 32.38	 <0.0001	
Female	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		45-54	 94	 1.69	 75,434	 1.25	(1.01-1.53)	 1.25	(01.01-1.53)	 110	 1.36	 75,707	 1.45	(1.19-1.75)	 1.33	(1.09-1.60)	 17.02	 -19.53	 0.36	 6.48	 0.2733	
		55-64	 163	 2.94	 52,090	 3.13	(2.67-3.65)	 3.12	(2.66-3.64)	 446	 5.51	 68,404	 6.52	(5.93-7.15)	 6.47	(5.88-7.09)	 173.62	 87.41	 31.32	 107.08	 <0.0001	
		65-74	 414	 7.46	 36,890	 11.22	(10.17-12.35)	 11.17	(10.13-12.29)	 694	 8.57	 42,887	 16.18	(15.01-17.42)	 16.79	(15.57-18.07)	 67.63	 14.88	 16.26	 50.27	 <0.0001	
		75-84	 1,623	 29.26	 31,110	 52.17	(49.73-54.70)	 51.30	(48.90-53.79)	 2,034	 25.11	 29,801	 68.25	(65.42-71.18)		 66.75	(63.97-69.61)	 25.32	 -14.18	 -4.21	 30.11	 <0.0001	
		85+	 3,252	 58.64	 17,788	 182.82	(177.16-188.58)	 179.17	(173.63-184.82)	 4,815	 59.45	 20,082	 239.77	(233.88-245.73)	 222.14	(216.68-227.66)	 48.06	 1.38	 12.90	 23.98	 <0.0001	
		All	ages	 5,546	 100.00	 213,312	 26.00	(25.33-26.68)	 21.88	(21.21-22.45)	 8,099	 100.00	 236,881	 34.19	(33.46-34.93)	 28.33	(27.73-28.94)	 46.03	 0.00	 11.05	 29.48	 <0.0001	
Male	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		45-54	 88	 2.71	 77,504	 1.14	(0.91-1.40)	 1.13	(0.91-1.39)	 101	 2.06	 77,693	 1.30	(1.06-1.58)	 1.19	(0.97-1.45)	 14.77	 -23.99	 0.24	 5.39	 0.3354	
		55-64	 216	 6.65	 53,095	 4.07	(3.55-4.65)	 4.08	(3.55-4.66)	 430	 8.75	 70,388	 6.11	(5.55-6.71)	 	6.06	(5.50-6.66)	 99.07	 31.58	 32.57	 48.72	 <0.0001	
		65-74	 438	 13.48	 34,559	 12.67	(11.52-13.91)	 12.74	(11.58-13.98)	 697	 14.19	 41,702	 16.71	(15.51-17.99)	 	17.52	(16.25-18.86)	 59.13	 5.27	 20.67	 37.54	 <0.0001	
		75-84	 1,153	 35.49	 24,381	 47.29	(44.66-50.03)	 48.33	(45.65-51.13)	 1,653	 33.65	 24,502	 67.46	(64.35-70.68)	 67.66	(64.54-70.89)	 43.37	 -5.18	 0.50	 39.99	 <0.0001	
		85+	 1,354	 41.67	 9,067	 149.33	(142.06-156.84)	 155.55	(147.97-163.36)	 2,032	 41.36	 10,858	 187.14	(179.85-194.61)	 192.66	(185.15-200.35)	 50.07	 -0.74	 19.75	 23.86	 <0.0001	
		All	ages	 3,249	 100.00	 198,606	 16.36	(15.81-16.93)	 20.51	(19.81-21.22)	 4,913	 100.00	 225,143	 21.82	(21.22-22.43)	 27.15	(26.40-27.91)	 51.22	 0.00	 13.36	 32.38	 <0.0001	
Overall	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
		45-54	 182	 2.07	 152,938	 1.19	(1.02-1.38)	 1.19	(1.02-1.38)	 211	 1.62	 153,400	 1.38	(1.20-1.57)	 1.26	(1.10-1.44)	 15.93	 -21.74	 0.30	 5.97	 0.1512	
		55-64	 379	 4.31	 105,185	 3.60	(3.25-3.98)	 3.60	(3.25-3.98)	 876	 6.73	 138,792	 6.31	(5.90-6.74)	 6.26	(5.86-6.69)	 131.13	 56.15	 31.95	 73.77	 <0.0001	
		65-74	 852	 9.69	 71,449	 11.93	(11.14-12.75)	 11.93	(11.14-12.75)	 1,391	 10.69	 84,589	 16.44	(15.60-17.32)	 17.15	(16.26-18.06)	 63.26	 10.32	 18.39	 43.77	 <0.0001	
		75-84	 2,776	 31.56	 55,491	 50.03	(48.23-51.87)	 50.03	(48.23-51.87)	 3,687	 28.34	 54,303	 67.90	(65.80-70.05)	 67.16	(65.08-69.28)	 32.82	 -10.20	 -2.14	 34.24	 <0.0001	
		85+	 4,606	 52.37	 26,855	 171.51	(167.02-176.08)	 171.51	(167.02	–	176.08)	 6,847	 52.62	 30,940	 221.30	(216.68-225.97)	 212.49	(208.06-216.97)	 48.65	 0.48	 15.21	 23.89	 <0.0001	
		All	ages	 8,795	 100.00	 411,918	 21.35	(20.91-21.80)	 21.35	(20.91-21.80)	 13,012	 100.00	 462,024	 28.16	(27.69-28.64)	 27.87	(27.40-28.35)	 47.95	 0.00	 12.16	 30.54	 <0.0001	
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